We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.69B
AUM Growth
+$108M
Cap. Flow
-$1.54M
Cap. Flow %
-0.09%
Top 10 Hldgs %
32.32%
Holding
211
New
11
Increased
45
Reduced
84
Closed
4

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.77M
2
MTD icon
Mettler-Toledo International
MTD
+$2.46M
3
ALB icon
Albemarle
ALB
+$2.34M
4
NKE icon
Nike
NKE
+$1.67M
5
ROK icon
Rockwell Automation
ROK
+$1.67M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$6.64M
2
GEV icon
GE Vernova
GEV
+$3.03M
3
MDT icon
Medtronic
MDT
+$1.91M
4
MSFT icon
Microsoft
MSFT
+$1.64M
5
ZBH icon
Zimmer Biomet
ZBH
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 28.35%
2 Healthcare 17.96%
3 Industrials 17.05%
4 Financials 9.04%
5 Materials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VO icon
126
Vanguard Mid-Cap ETF
VO
$106B
$662K 0.04%
10,036
– –
MMM icon
127
3M
MMM
$92.5B
$651K 0.04%
4,765
-84
-2% -$10.3K
VPL icon
128
Vanguard FTSE Pacific ETF
VPL
$7.77B
$639K 0.04%
8,150
– –
RSP icon
129
Invesco S&P 500 Equal Weight ETF
RSP
$97.7B
$623K 0.04%
3,480
+1,040
+43% +$178K
FISV
130
Fiserv Inc
FISV
$29.6B
$619K 0.04%
3,446
– –
WMT icon
131
Walmart Inc
WMT
$904B
$604K 0.04%
7,479
-1,347
-15% -$98.9K
ACN icon
132
Accenture
ACN
$108B
$598K 0.04%
1,692
– –
BP icon
133
BP
BP
$112B
$595K 0.04%
18,968
– –
AZN icon
134
AstraZeneca
AZN
$271B
$579K 0.03%
3,713
-728
-16% -$118K
VB icon
135
Vanguard Small-Cap ETF
VB
$79B
$570K 0.03%
2,404
– –
DE icon
136
Deere & Co
DE
$165B
$569K 0.03%
1,363
-90
-6% -$33.9K
LOW icon
137
Lowe's Companies
LOW
$122B
$540K 0.03%
1,994
-300
-13% -$72.7K
ORLY icon
138
O'Reilly Automotive
ORLY
$75.5B
$531K 0.03%
6,915
– –
VEA icon
139
Vanguard FTSE Developed Markets ETF
VEA
$223B
$528K 0.03%
9,991
– –
PPLI
140
People Inc
PPLI
$3.13B
$513K 0.03%
11,630
-10,913
-48% -$455K
NFLX icon
141
Netflix
NFLX
$302B
$505K 0.03%
7,120
-680
-9% -$45.5K
WST icon
142
West Pharmaceutical
WST
$23.5B
$500K 0.03%
1,667
-351
-17% -$107K
IBM icon
143
IBM
IBM
$213B
$493K 0.03%
2,232
– –
ED icon
144
Consolidated Edison
ED
$41.5B
$474K 0.03%
4,555
– –
VLTO icon
145
Veralto
VLTO
$24.3B
$459K 0.03%
4,099
-18
-0.4% -$1.9K
AME icon
146
Ametek
AME
$53.8B
$433K 0.03%
2,522
– –
AMT icon
147
American Tower
AMT
$80.7B
$426K 0.03%
1,831
– –
CSCO icon
148
Cisco
CSCO
$454B
$423K 0.03%
7,953
– –
EFA icon
149
iShares MSCI EAFE ETF
EFA
$76.3B
$412K 0.02%
4,921
-20
-0.4% -$1.61K
CRM icon
150
Salesforce
CRM
$154B
$401K 0.02%
1,464
-7
-0.5% -$1.79K
4 5
6
7 8

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q3 2024 Portfolio in Review

As of Q3 2024, Grandfield & Dodd held 211 positions worth $1.69B, up 6.8% from $1.58B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q3 2024 filing shows 11 new, 45 increased, 84 reduced and 4 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 1,224 shares worth $337K. The largest sale was Berkshire Hathaway Class A, an estimated $6.64M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2024 buy was Alnylam Pharmaceuticals: 1,224 shares worth $337K.
  • Grandfield & Dodd added most to Alphabet (Google) Class A in Q3 2024, an estimated $3.77M increase.
  • Grandfield & Dodd's biggest Q3 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $6.64M.
  • Grandfield & Dodd fully exited Charles Schwab in Q3 2024, selling an estimated $265K.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.69B portfolio in Q3 2024.
  • Grandfield & Dodd opened 11 new positions and closed 4 in Q3 2024.
  • Grandfield & Dodd's portfolio value rose 6.8% quarter-over-quarter to $1.69B.

Based on Grandfield & Dodd's 13F filing for Q3 2024, filed 8 Nov 2024.